STEADY-STATE OXIDATION OF GLUCOSE IN THE DIABETIC RAT

1960 ◽  
Vol 38 (12) ◽  
pp. 1471-1478 ◽  
Author(s):  
Dorothy S. Dow ◽  
C. E. Allen

The single intraperitoneal injection of a labelled glucose load has been shown to maintain the specific activities of blood glucose and expired CO2 at constant levels for extended periods of time. These plateaus have been established in both the fed control and the fed diabetic rat. The results have been interpreted as indicating the existence of a steady state in the labelled system under study.Measurements have been made of rates of oxidation of glucose-1-C14 and giucose-6-C14 in diabetic and control rats during this steady state between the specific activities of blood glucose and expired CO2. The results indicate no reduction either for the glycolytic or for the phosphogluconate pathway in the diabetic. No change in the ratio between the oxidative rates for the two pathways has been found.


1960 ◽  
Vol 38 (1) ◽  
pp. 1471-1478 ◽  
Author(s):  
Dorothy S. Dow ◽  
C. E. Allen

The single intraperitoneal injection of a labelled glucose load has been shown to maintain the specific activities of blood glucose and expired CO2 at constant levels for extended periods of time. These plateaus have been established in both the fed control and the fed diabetic rat. The results have been interpreted as indicating the existence of a steady state in the labelled system under study.Measurements have been made of rates of oxidation of glucose-1-C14 and giucose-6-C14 in diabetic and control rats during this steady state between the specific activities of blood glucose and expired CO2. The results indicate no reduction either for the glycolytic or for the phosphogluconate pathway in the diabetic. No change in the ratio between the oxidative rates for the two pathways has been found.



1961 ◽  
Vol 39 (6) ◽  
pp. 981-990 ◽  
Author(s):  
Dorothy S. Dow ◽  
C. E. Allen

The single intraperitoneal injection of a labelled glucose load has been shown to maintain a steady state with respect to the specific activities of blood glucose and expired CO2for extended periods of time in hyperthyroid and hypothyroid rats. Measurements were made of rates of oxidation of glucose-1-C14and glucose-6-C14during the steady state.The results indicate that glucose oxidation by way of the glycolytic pathway is markedly elevated in the hyperthyroid rat and parallels the increased rate of CO2expiration. Glucose oxidation by way of the hexose monophosphate pathway is completely suppressed. This effect is considered to be due to the preferential maintenance of diphosphopyridine nucleotide in the reduced form.In the hypothyroid rat a decreased rate of glucose oxidation by way of both oxidative pathways parallels the decreased rate of CO2production.The results support the view that the primary action of thyroxine is on oxidative activity. The observed effect on the hexose monophosphate pathway appears to be secondary.



1963 ◽  
Vol 41 (5) ◽  
pp. 1293-1305
Author(s):  
Dorothy S. Dow ◽  
C. E. Allen

A steady state between the specific activities of blood glucose and expired CO2in the hypothyroid diabetic rat was maintained for extended periods of time following a single intraperitoneal injection of glucose-1-C14or glucose-6-C14. Rates of oxidation of the labelled sugars were measured during the steady state.Glucose oxidation by way of glycolysis and the tricarboxylic acid cycle in the hypothyroid diabetic rat paralleled the decrease in expired CO2but glucose oxidation by way of the hexose monophosphate pathway was completely suppressed.It is suggested that the observed inhibitory effect on the hexose monophosphate pathway is due to the maintenance of diphosphopyridine nucleotide in the reduced form as the result of goitrogen inhibition of steroid-catalyzed transhydrogenation.The results suggest that steroid concentration may be a critical factor in regulation of glucose oxidation by way of the hexose monophosphate pathway.



2011 ◽  
Vol 114 (1) ◽  
pp. 85-91 ◽  
Author(s):  
Rami Abu Fanne ◽  
Taher Nassar ◽  
Achinoam Mazuz ◽  
Otailah Waked ◽  
Samuel N. Heyman ◽  
...  

Object The severity of neurological impairment following traumatic brain injury (TBI) is exacerbated by several endogenous processes, including hyperglycemia, hypotension, and the generation of glutamate. However, in addition to controlling hyperglycemia, insulin has pleiotropic effects on tissue metabolism, which include reducing the concentration of the neurotoxic amino acid glutamate, making it unclear whether insulin's beneficial effects are attributable to the establishment of euglycemia per se. In the present study, the authors asked if reducing glutamate via approaches that do not lower glucose levels would improve neurological outcome following TBI. Methods Glucagon activates gluconeogenesis by increasing the hepatic uptake of amino acids such as glutamate and facilitating their conversion to glucose. Glucagon was administered as a single intraperitoneal injection before or after closed head injury (CHI). Neurological function, brain histological features, blood glutamate and glucose levels, and CSF glutamate concentrations were measured. Results A single intraperitoneal injection of glucagon (25 μg) into mice 10 minutes before or after CHI reduced lesion size by about 60% (p < 0.0001) and accelerated neurological recovery. The neuroprotective effect of glucagon was related to gluconeogenesis by decreasing the concentration of the neuroexcitatory amino acid glutamate in the circulation from 207 ± 32.1 μmol/L in untreated mice to 101.11 ± 21.6 μmol/L in treated mice (p < 0.001); a similar effect occurred in the CSF. The neuroprotective effect of glucagon was seen notwithstanding the attendant increase in blood glucose, the final substrate of gluconeogenesis. Conclusions Glucagon exerts a marked neuroprotective effect post-TBI by decreasing CNS glutamate. Glucagon was beneficial despite increasing blood glucose. Favorable effects also occurred when glucagon was given prior to TBI, suggesting its involvement in the preconditioning process. Thus, glucagon may be of value in providing neuroprotection when administered after TBI or prior to certain neurosurgical or cardiac interventions in which the incidence of perioperative ischemia is high.



2010 ◽  
Vol 109 (5) ◽  
pp. 1347-1353 ◽  
Author(s):  
Steven W. Copp ◽  
K. Sue Hageman ◽  
Brad J. Behnke ◽  
David C. Poole ◽  
Timothy I. Musch

The purpose of the present investigation was to examine the muscle hyperemic response to steady-state submaximal running exercise in the Goto-Kakizaki (GK) Type II diabetic rat. Specifically, the hypothesis was tested that Type II diabetes would redistribute exercising blood flow toward less oxidative muscles and muscle portions of the hindlimb. GK diabetic ( n = 10) and Wistar control ( n = 8, blood glucose concentration, 13.7 ± 1.6 and 5.7 ± 0.2 mM, respectively, P < 0.05) rats were run at 20 m/min on a 10% grade. Blood flows to 28 hindlimb muscles and muscle portions as well as the abdominal organs and kidneys were measured in the steady state of exercise using radiolabeled 15-μm microspheres. Blood flow to the total hindlimb musculature did not differ between GK diabetic and control rats (161 ± 16 and 129 ± 15 ml·min−1·100g−1, respectively, P = 0.18). Moreover, there was no difference in blood flow between GK diabetic and control rats in 20 of the individual muscles or muscle parts examined. However, in the other eight muscles examined that typically are comprised of a majority of fast-twitch glycolytic (IIb/IIdx) fibers, blood flow was significantly greater (i.e., ↑31–119%, P < 0.05) in the GK diabetic rats. Despite previously documented impairments of several vasodilatory pathways in Type II diabetes these data provide the first demonstration that a reduction of exercising muscle blood flow during submaximal exercise is not an obligatory consequence of this condition in the GK diabetic rat.



1971 ◽  
Vol 41 (6) ◽  
pp. 545-553 ◽  
Author(s):  
D. J. Galton ◽  
J. P. D. Wilson

1. The activities of hexokinase (EC 2.7.1.1) and phosphofructokinase (EC 2.7.1.11) have been studied in homogenates of adipose tissue taken from human diabetics, fasting and control patients. 2. Three isoenzymes of hexokinase were observed with apparent Km values for glucose of 1.04 × 10-5 m, 2.6 × 10-4 m and 2.9 × 10-4 m, respectively. 3. No change in activity of hexokinase was found in adipose tissue of untreated diabetics (n = 22), treated diabetics (n = 13) or non-diabetic controls. However, fasting was associated with a decrease of approx. 40% in the activity of hexokinase in adipose tissue. 4. In contrast, there was a marked decrease in the activity of phosphofructokinase in adipose tissue from untreated diabetics (n = 24) which was restored to normal by either insulin therapy or treatment by hypoglycaemic drugs. 5. There was a negative correlation between the phosphofructokinase/hexokinase ratio in adipose tissue and the fasting blood glucose (P = 0.01) and the 2 h blood glucose (P = 0.03) after an oral glucose load (50 g). 6. The functional significance of the changes in enzyme activities is discussed in relation to the glucose intolerance of diabetes.



1963 ◽  
Vol 41 (1) ◽  
pp. 1293-1305
Author(s):  
Dorothy S. Dow ◽  
C. E. Allen

A steady state between the specific activities of blood glucose and expired CO2in the hypothyroid diabetic rat was maintained for extended periods of time following a single intraperitoneal injection of glucose-1-C14or glucose-6-C14. Rates of oxidation of the labelled sugars were measured during the steady state.Glucose oxidation by way of glycolysis and the tricarboxylic acid cycle in the hypothyroid diabetic rat paralleled the decrease in expired CO2but glucose oxidation by way of the hexose monophosphate pathway was completely suppressed.It is suggested that the observed inhibitory effect on the hexose monophosphate pathway is due to the maintenance of diphosphopyridine nucleotide in the reduced form as the result of goitrogen inhibition of steroid-catalyzed transhydrogenation.The results suggest that steroid concentration may be a critical factor in regulation of glucose oxidation by way of the hexose monophosphate pathway.



1972 ◽  
Vol 50 (6) ◽  
pp. 714-717 ◽  
Author(s):  
Albert Y. Chang

Chronic diabetic rat, induced by streptozotocin, showed high blood glucose but low liver glycogen levels. The diabetic liver had subnormal amounts of glycogen synthetase and its I form when assayed in both 8000 × g supernatant and glycogen pellet suspensions. The pellet suspension of the control liver retained 68% synthetase I activity; the diabetic liver retained only 19.5%. The addition of deproteinized liver extract to the pellet suspension increased the activity of synthetase either in the presence or absence of glucose-6-PO4 for both groups of animals to different degrees. The deproteinized liver extract of the diabetic rat contained little ATP, less glucose-6-PO4, and slightly more inorganic phosphate than that of the control rat. The significance of these observations is discussed.





Sign in / Sign up

Export Citation Format

Share Document